Ralliant Corporation $RAL Stock Holdings Lifted by Gabelli Funds LLC

Gabelli Funds LLC increased its position in shares of Ralliant Corporation (NYSE:RAL) by 28.2% during the first quarter, Holdings Channel reports. The fund owned 38,257 shares of the company’s stock after acquiring an additional 8,421 shares during the quarter. Gabelli Funds LLC’s holdings in Ralliant were worth $1,591,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. Allworth Financial LP boosted its stake in Ralliant by 134.4% in the 4th quarter. Allworth Financial LP now owns 511 shares of the company’s stock worth $26,000 after purchasing an additional 293 shares during the period. Rothschild Investment LLC raised its stake in Ralliant by 98.1% during the 4th quarter. Rothschild Investment LLC now owns 612 shares of the company’s stock valued at $31,000 after purchasing an additional 303 shares during the period. Keybank National Association OH raised its stake in Ralliant by 1.6% during the 4th quarter. Keybank National Association OH now owns 19,667 shares of the company’s stock valued at $1,001,000 after purchasing an additional 305 shares during the period. UMB Bank n.a. lifted its holdings in shares of Ralliant by 49.6% in the fourth quarter. UMB Bank n.a. now owns 983 shares of the company’s stock valued at $50,000 after purchasing an additional 326 shares in the last quarter. Finally, Maryland State Retirement & Pension System lifted its holdings in shares of Ralliant by 1.5% in the fourth quarter. Maryland State Retirement & Pension System now owns 21,940 shares of the company’s stock valued at $1,117,000 after purchasing an additional 329 shares in the last quarter.

Ralliant Trading Down 1.3%

Shares of NYSE:RAL opened at $66.85 on Thursday. The firm has a fifty day moving average of $66.98 and a two-hundred day moving average of $54.16. The firm has a market capitalization of $7.48 billion and a P/E ratio of -6.11. Ralliant Corporation has a 12-month low of $37.27 and a 12-month high of $75.41. The company has a quick ratio of 1.05, a current ratio of 1.61 and a debt-to-equity ratio of 0.73.

Ralliant (NYSE:RAL) last posted its quarterly earnings results on Tuesday, May 12th. The company reported $0.57 earnings per share for the quarter, topping analysts’ consensus estimates of $0.49 by $0.08. Ralliant had a negative net margin of 58.55% and a positive return on equity of 12.49%. The business had revenue of $534.60 million for the quarter. The firm’s revenue was up 11.0% compared to the same quarter last year. Ralliant has set its FY 2026 guidance at 2.530-2.690 EPS and its Q2 2026 guidance at 0.580-0.640 EPS. On average, equities analysts expect that Ralliant Corporation will post 2.64 EPS for the current fiscal year.

Ralliant Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 23rd. Shareholders of record on Monday, June 8th were paid a $0.05 dividend. The ex-dividend date was Monday, June 8th. This represents a $0.20 dividend on an annualized basis and a yield of 0.3%. Ralliant’s payout ratio is -1.83%.

Analyst Upgrades and Downgrades

Several analysts have recently commented on the company. Citigroup raised their target price on Ralliant from $70.00 to $81.00 and gave the stock a “buy” rating in a research report on Monday, July 13th. Vertical Research lowered Ralliant from a “buy” rating to a “hold” rating and set a $65.00 price target on the stock. in a research report on Wednesday, May 27th. Royal Bank Of Canada increased their price objective on Ralliant from $64.00 to $71.00 and gave the stock a “sector perform” rating in a research note on Thursday, July 16th. Zacks Research upgraded Ralliant from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, June 30th. Finally, Oppenheimer lifted their target price on Ralliant from $50.00 to $65.00 and gave the company an “outperform” rating in a research note on Wednesday, May 13th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $73.00.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.